Carcinogenesis Advance Access published online on January 3, 2008
Carcinogenesis, doi:10.1093/carcin/bgm296
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stromal resistance of fibroblasts against oxidative damage: Involvement of tumor cell-secreted platelet derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation
Institute of Biochemistry & Molecular Biology I, Heinrich-Heine-University, D-40225 Düsseldorf, Germany
* Corresponding author: Peter Brenneisen, PhD, Institut für Biochemie & Molekularbiologie I, Universitätsstrasse 1, 40225 Düsseldorf/Germany, phone: +492118112715, fax: +492118113029, email: PeterBrenneisen{at}web.de
A critical step in tumor progression is the interaction of malignant and stromal cells via paracrine mechanisms. Stromal cells, particularly fibroblasts, support cancer cells in invasion of the surrounding tissue for access to the vascular system. Here, the question is addressed of whether tumor cells induce stromal resistance, i.e. protect the microenvironment from oxidative damage. The supernatant of cultured skin-derived tumor cells was added to fibroblasts and was shown to protect the fibroblasts from hydrogen peroxide-mediated cell toxicity. The platelet-derived growth factor (PDGF) secreted from the cancer cells was identified as trigger of this protection in fibroblasts via the phosphoinositide 3-kinase (PI3K) pathway. These data suggest that pro-survival signals in stromal fibroblasts as initiated by tumor cells constitute a strategy of stromal resistance, illustrating a novel biological role of fibroblasts for the tumor microenvironment.
Key Words: tumor-stroma fibroblast reactive oxygen species paracrine effect PDGF PI3K
Received September 4, 2007; revised December 17, 2007; accepted December 17, 2007.